PPARA and Parkinson disease: Preliminary results demonstrate that PPAR-alpha activation by fenofibrate prevents death of dopaminergic neurons of substantia nigra pars compacta in the MPTP model of Parkinson's disease, while another PPAR-α agonists bezafibrate had no effect in MPTP model.